Scholar Rock (NASDAQ: SRRK) has resubmitted its Marketing Authorisation Application (MAA) for apitegromab to the European Medicines Agency (EMA) for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA